Concomitant Peripheral and Pulmonary Arterial Thromboembolism 35 Days After SARS-CoV-2 mRNA Vaccine
Although thromboembolism after ChAdOx1 vaccine has been extensively reported, this association was rarely reported after vaccination with BNT162b2. We present the case of an otherwise healthy patient who developed concomitant acute limb ischemia and extensive pulmonary embolism (PE) 35 days after th...
Main Authors: | Ahmet Can Topçu, Abdurrahman Ekinci, Nihan Kayalar, Mehmed Yanartaş |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2023-04-01
|
Series: | Cam & Sakura Medical Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=csmedj&un=CSM-25744 |
Similar Items
-
Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
by: Cynthia M. Rohde, et al.
Published: (2023-02-01) -
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey
by: Makoto Yoshida, et al.
Published: (2022-03-01) -
Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers
by: Michela Deiana, et al.
Published: (2021-08-01) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
by: Mohammad Altermanini, et al.
Published: (2023-08-01) -
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients
by: Hirai K, et al.
Published: (2024-05-01)